GCET2 antibody

Catalog No. ABIN5026982

Product Details anti-GCET2 Antibody

Target: GCET2 (Germinal Center Expressed Transcript 2 (GCET2))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This GCET2 antibody is un-conjugated

Application: Immunohistochemistry (IHC)

Purification: Protein G Chromatography

Immunogen: A full length human HGAL protein was used as the immunogen for this antibody

Clone: ABM43E6

Isotype: IgG1 kappa

Application Details

Application Notes: IHC: 5 μg/mL

Restrictions: For Research Use only

Handling

Concentration: 0.5 mg/mL

Buffer: PBS containing 0.05 % BSA, PH 7.4

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.

Target Details for GCET2

Target: GCET2 (Germinal Center Expressed Transcript 2 (GCET2))

Alternative Name: HGAL (GCET2 Products)

Synonyms: Gcet antibody, Gcet2 antibody, M17 antibody, M17-L antibody, GCAT2 antibody, GCET2 antibody, HGAL antibody, germinal center associated, signaling and motility antibody, germinal center associated signaling and motility antibody, germinal center-associated, signaling and motility antibody, Gcsam antibody, GCSAM antibody

Background: Human germinal center-associated lymphoma (HGAL) is specifically expressed only in germinal center (GC), B lymphocytes and GC-derived lymphomas. It is located on chromosome 3q13, comprises 6 exons and encodes a cytoplasmic protein of 178 amino acids that contains an immunoreceptor tyrosine-based activation motif (ITAM). HGAL decreases lymphocyte motility by inhibiting the ability of myosin to translocate actin via direct interaction with F-actin and myosin II and by activating RhoA signaling via direct interactions with RhoA-specific guanine nucleotide exchange factors. It also regulates B-cell receptor (BCR) signaling by directly binding to and enhancing Syk kinase activity and activation of its downstream effectors (Ref-1). HGAL expression by tumor cells correlates with a favorable prognosis in patients with diffuse large B-cell and classical Hodgkin lymphomas.

Gene ID: 257144

UniProt: Q8N6F7